INSP - Inspire Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD
56.65
-0.34 (-0.60%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close56.99
Open57.33
Bid0.00 x 900
Ask56.68 x 800
Day's Range56.53 - 57.98
52 Week Range34.81 - 64.34
Volume290,733
Avg. Volume298,840
Market Cap1.349B
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.17
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est62.29
Trade prices are not sourced from all markets
  • GlobeNewswirelast month

    Inspire Medical Systems, Inc. Announces Publication Demonstrating Effectiveness of Inspire Therapy in Treating Obstructive Sleep Apnea in Medicare-aged Patients

    The publication, entitled “Upper Airway Stimulation Response in Older Adults with Moderate to Severe Obstructive Sleep Apnea,” appears online in the Journal of Otolaryngology – Head and Neck Surgery (DOI: 10.1177/0194599819848709 http://otojournal.org). “This study corroborates the growing evidence supporting the safety and efficacy of Inspire therapy for the treatment of OSA in properly selected CPAP-intolerant cases,” said Dr. Kirk Withrow, Associate Professor at the University of Alabama Birmingham and lead author of this publication. “We received feedback from several of the regional Medicare administrators indicating the need for published literature that specifically evaluated Medicare-aged patients receiving Inspire therapy,” said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems.

  • GlobeNewswirelast month

    Inspire Medical Systems, Inc. to Present at the 2019 RBC Capital Markets Global Healthcare Conference

    Inspire Medical Systems, Inc. (INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the 2019 RBC Capital Markets Global Healthcare Conference on May 22, 2019 at the InterContinental New York Barclay in New York City. Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

  • Inspire Medical Systems, Inc. (INSP) Q1 2019 Earnings Call Transcript
    Motley Foollast month

    Inspire Medical Systems, Inc. (INSP) Q1 2019 Earnings Call Transcript

    INSP earnings call for the period ending March 31, 2019.

  • Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates
    Zackslast month

    Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates

    Inspire (INSP) delivered earnings and revenue surprises of 10.26% and 13.24%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Presslast month

    Inspire: 1Q Earnings Snapshot

    On a per-share basis, the Golden Valley, Minnesota-based company said it had a loss of 35 cents. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment ...

  • ACCESSWIRElast month

    Inspire Medical Systems, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 7, 2019 / Inspire Medical Systems, Inc. (NYSE: INSP ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 7, 2019 at 5:00 PM ...

  • GlobeNewswirelast month

    Inspire Medical Systems, Inc. Announces Additional 11.2 Million Covered Lives with New Blue Cross Blue Shield Coverage Policies

    Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today the addition of three new Blue Cross Blue Shield Association (“BCBSA”) plans, including Blue Cross Blue Shield of Michigan, Blue Shield of California and Excellus Blue Cross Blue Shield, adding 11.2 million covered lives to the growing slate of positive coverage policies of Inspire therapy.

  • Hedge Funds Have Never Been This Bullish On Inspire Medical Systems, Inc. (INSP)
    Insider Monkey2 months ago

    Hedge Funds Have Never Been This Bullish On Inspire Medical Systems, Inc. (INSP)

    We can judge whether Inspire Medical Systems, Inc. (NYSE:INSP) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There's no better way to get these firms' immense resources and analytical capabilities working for us than to follow their lead into their […]

  • GlobeNewswire2 months ago

    Inspire Medical Systems, Inc. to Present at the Bank of America Merrill Lynch Health Care Conference 2019

    Inspire Medical Systems, Inc. (INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the Bank of America Merrill Lynch Health Care Conference 2019 on Thursday, May 16 at the Encore Hotel in Las Vegas, Nevada. Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

  • Inspire Medical Systems (INSP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    Zacks2 months ago

    Inspire Medical Systems (INSP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire2 months ago

    Inspire Medical Systems, Inc. Announces an Additional 10.4 Million Covered Lives with New Coverage Policies

    MINNEAPOLIS, April 25, 2019 -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of.

  • GlobeNewswire2 months ago

    Inspire Medical Systems, Inc. Announces the 5,000th Patient to Receive Inspire Therapy

    Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that the 5,000th patient has been implanted with Inspire therapy since the inception of the program.  The 5,000th procedure was performed by Dr. Christopher Larsen at The University of Kansas Health System (TUKHS) in Kansas City, Kansas. “This is simply a tremendous and very significant milestone for Inspire,” said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems.

  • GlobeNewswire2 months ago

    Inspire Medical Systems, Inc. to Report First Quarter 2019 Financial Results on May 7, 2019

    MINNEAPOLIS, April 09, 2019 -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of.

  • GlobeNewswire2 months ago

    Inspire Medical Systems, Inc. Announces Three New Positive Coverage Policies Issued by Blue Cross Blue Shield Plans

    Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that three new Blue Cross Blue Shield Association (“BCBSA”) healthcare plans have issued positive coverage policies of Inspire therapy.

  • GlobeNewswire4 months ago

    Inspire Medical Systems, Inc. Announces Five New Positive Coverage Policies Issued by Blue Cross Blue Shield Plans

    MINNEAPOLIS, March 04, 2019 -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of.

  • Inspire Medical Systems, Inc. (INSP) Q4 2018 Earnings Conference Call Transcript
    Motley Fool4 months ago

    Inspire Medical Systems, Inc. (INSP) Q4 2018 Earnings Conference Call Transcript

    INSP earnings call for the period ending December 31, 2018.

  • GlobeNewswire4 months ago

    Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results

    MINNEAPOLIS, Feb. 26, 2019 -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of.

  • GlobeNewswire4 months ago

    Inspire Medical Systems, Inc. to Present at the 8th Annual SVB Leerink Global Healthcare Conference

    Inspire Medical Systems, Inc. (INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the 8th Annual SVB Leerink Global Healthcare Conference on February 28, 2019 at the Lotte New York Palace in New York. Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

  • Motley Fool4 months ago

    4 Disruptive Healthcare Stocks You've Never Heard Of

    Do these under-the-radar stocks deserve a spot in your growth stock portfolio?

  • GlobeNewswire4 months ago

    Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2018 Financial Results on February 26

    MINNEAPOLIS, Feb. 05, 2019 -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of.

  • GlobeNewswire4 months ago

    Inspire Medical Systems, Inc. Announces Additional Positive Coverage Policies Issued by Five Blue Cross Blue Shield Healthcare Plans

    MINNEAPOLIS, Feb. 05, 2019 -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of.

  • What's in the Cards for Match Group (MTCH) in Q4 Earnings?
    Zacks5 months ago

    What's in the Cards for Match Group (MTCH) in Q4 Earnings?

    Match Group (MTCH) is benefiting from increasing subscriber addition in the form of membership subscriptions. Tinder remains the key catalyst.

  • GlobeNewswire5 months ago

    Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Blue Cross Blue Shield of North Carolina

    Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that Blue Cross Blue Shield of North Carolina (“BCBSNC”) has issued a positive coverage policy of Inspire therapy. This is the third coverage policy issued by a Blue Cross Blue Shield Association (“BCBSA”) healthcare plan following BCBSA Evidence Street’s January 7, 2019 report, which stated that there is sufficient evidence to determine that Inspire therapy results in a meaningful improvement in net health outcomes for patients meeting specified criteria.  BCBSNC, an independent licensee of BCBSA, is the state of North Carolina’s largest insurer and covers approximately 3.9 million members.

  • GlobeNewswire5 months ago

    Inspire Medical Systems, Inc. Announces FDA Approval of New Sensing Lead

    “We are pleased to receive FDA approval of the new sensing lead for Inspire therapy,” said Tim Herbert, President and Chief Executive Officer of Inspire Medical Systems. Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.